Scientists from across the world who are attending the International Congress of Immunology in Melbourne have learnt about ground-breaking immunology research taking place at Hudson Institute of Medical Research.
Around 20 delegates from 11 countries including USA, Brazil, Iran, South Korea and Norway toured the Monash Health Translation Precinct, including the $87.5 million Translational Research Facility on Tuesday (August 23).
The visitors ranged from undergraduate students to postdoctoral researchers and lab heads, with diverse research interests in immunology, ranging from malaria to cancer and vaccines.
Scientists from Hudson Institute and School of Clinical Sciences at Monash Health presented on their breakthrough immunology research into diseases including lung cancer, emphysema, neonatal diseases and vasculitis.
Professor Brendan Jenkins, Head of Hudson’s Centre for Innate Immunity and Infectious Diseases at Hudson Institute, said the breadth of both the immunology research and facilities at MHTP impressed visitors.
“The delegates that visited had wide-ranging research interests, ranging from cytokine and cellular immunology, to cancer, and vaccines and the ageing immune system,” Professor Jenkins said.
“We were able to present a snapshot of the leading basic and translational research on the immune system which is being undertaken at the MHTP site, which was very well received by the visiting delegates”.
The tour showcased immunology labs as well as the Clinical Trials Centre and platform technologies floor of the Translational Research Facility.
More than 3800 scientists are in Melbourne for the week-long International Congress of Immunology, the largest global event in the field of immunology.
A number of Hudson Institute scientists, A/Prof Ashley Mansell, Dr Michael Gantier, Dr Michelle Tate, Dr Claudia Nold and Dr Ina Rudloff are presenting their research at ICI.
Engagement tours have taken place at institutions across Melbourne, including the Burnet Institute, the Peter Doherty Institute for Infection and Immunity, the Olivia Newton-John Cancer Research Institute, Peter MacCallum Cancer Centre and the Walter and Eliza Hall Institute.
Contact us
Hudson Institute communications
t: +61 3 8572 2697
e: communications@hudson.org.au
